Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events icpe all access 2020
… a Marketing Specialist with RTI-HS. Ms. Howze’s focus is events, project managements, and content creation. She has a … Prior to joining RTI-HS, Ms. Howze served as a college access advisor. Her freelance writing has been featured in … su ch as The Washington Post , The Huffington Post , U.S. News & World Report , and MTV News. …
… HTA approval? Are apps, digital therapeutics, and devices all treated the same? How different are the requirements from … available worldwide. This category is broad and includes all technology, products, and services used for patient care, …
… economics, patient-centered outcomes research, market access, and pharmacoepidemiology. As the only non-profit, … and realistically with each other and our clients. See all of the policies that govern the way we work on the RTI … Our commitment to the Institute is the foundation for all other organizational commitments. Fiscal Responsibility …
… to target audiences. Proven Strategies for Market Access Back by popular demand, this webinar will guide you … involved in creating effective GVDs. Our experts in market access strategy and outcomes strategy will share proven … of stakeholders and assist you in the pharma market access process. Incorporate value messages and supporting …
… and documentation (including feasibility assessments, all versions of the study protocol, statistical analysis … that are fit for use, and the importance of providing FDA access to individual-level data. It also highlights the … collection and analysis. Because study monitoring, data access, and safety reporting are essential responsibilities, …
… Economic Review (ICER) released proposed changes to the 2020-2023 value assessment framework. In reviewing the … clinical effectiveness of new therapies, we recommend that all stakeholders developing new treatments marketed in the US … Medicare & Medicaid Services negotiation is expected among all active comparators and allow for prices of these drugs to …
… Union Anne Heyes, MBA Vice President, Head of Value & Access, Europe RTI Health Solutions Sweeping Developments in … rare diseases will be introduced from January 2028 and for all new medicines starting January 2030. And yes: line or … to address the specific perspectives and priorities of all the various healthcare stakeholders, particularly those …
… tools. Our instrument-development services apply to all modes of administration (e.g., paper, eCOA, web-based) …
… with eosinophilic esophagitis with high versus non-high all-cause costs: an analysis of insurance claims data. Xu X, …
… that many variables factor into the decision of how, if at all, a screening test should be used, including the …